Research and Markets: Cortex Pharmaceuticals, Inc. - Product Pipeline Review - 2012

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of Global Markets Direct's new company profile "Cortex Pharmaceuticals, Inc. - Product Pipeline Review - 2012" to their offering.

Global Markets Direct's pharmaceuticals report, Cortex Pharmaceuticals, Inc. - Product Pipeline Review - 2012 provides data on the Cortex Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Cortex Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Cortex Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Cortex Pharmaceuticals, Inc. - Brief Cortex Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of Cortex Pharmaceuticals, Inc. human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Cortex Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the Cortex Pharmaceuticals, Inc.'s pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Cortex Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of Cortex Pharmaceuticals, Inc. in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the Cortex Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Cortex Pharmaceuticals, Inc..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Cortex Pharmaceuticals, Inc. and identify potential opportunities in those areas.

For more information visit

Source: Global Markets Direct

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Source: Research and Markets